The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Gustav Smith

Associate professor

Default user image.

CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.

Author

  • Martin Annborn
  • Josef Dankiewicz
  • Niklas Nielsen
  • Malin Rundgren
  • Gustav Smith
  • S Hertel
  • J Struck
  • Hans Friberg

Summary, in English

Further characterization of the post-cardiac arrest syndrome (PCAS) is essential to better understand the mechanisms resulting in injury and death. We investigated serial serum concentrations of the stress hormone c-terminal provasopressin (CT-proAVP or copeptin), the cardiac biomarker MR-proANP and a biomarker of oxidation injury, Peroxiredoxin 4 (Prx4) in patients treated with mild hypothermia (MHT) after cardiac arrest, and studied their association to the PCAS and long-term outcome.

Department/s

  • Anesthesiology and Intensive Care
  • Cardiology
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2014

Language

English

Pages

428-436

Publication/Series

Acta Anaesthesiologica Scandinavica

Volume

58

Issue

4

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Anesthesiology and Intensive Care

Status

Published

ISBN/ISSN/Other

  • ISSN: 0001-5172